Studies show psilocybin from mushrooms could revolutionize depression treatment offering hope to millions who don't respond ...

A phase 2 clinical trial published in eClinicalMedicine and the US National Library of Medicine shows that psilocybin may be ...

Psilocybin-assisted psychotherapy (PAP) has been shown to potentially have mental health benefits for patients with cancer, ...

Mind-opening psychedelic drugs can provide a needed boost to people dealing with cancer or struggling with alcoholism, ...

A single dose of psilocybin may offer relief for patients with severe treatment-resistant depression, according to an ...

A psilocybin trial participant with treatment-resistant depression faced worsened suicidal thoughts and prolonged eating ...

The popularity of psilocybin is fast-rising, with an estimated 8 million American adults using it in 2023.  The percentage of US adults who have used psilocybin at least once in their lifetime, ...

Analysis of two trials indicates psilocybin-assisted psychotherapy may benefit the mental health of patients with cancer.

A study of older adults showed that 6% had depression, with higher prevalences in certain groups, including women, those who ...

Psilocybin is under clinical development by Filament Health and currently in Phase I for Major Depressive Disorder.

One or two doses of psilocybin, a compound found in psychedelic mushrooms, may improve the mental health of cancer patients when accompanied by psychotherapy, a new study suggests. A second new study ...

A nearly 200-page report from the Minnesota Psychedelic Medicine Task Force said psilocybin mushrooms show evidence they may ...